{"url_path":"/sec/bfriw/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1858685/0001493152-26-023119-index.html","accession_number":"0001493152-26-023119","cik":"0001858685","ticker":"BFRI","issuer_name":"Biofrontera Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1858685/0001493152-26-023119-index.html","primary_entity_key":"0001858685","primary_entity_name":"Biofrontera Inc."},"word_count":43,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nFor\ninformation regarding legal proceedings in which we are involved, see *Note 16. Commitments and Contingencies* under the\nsubsection titled “Legal Proceedings” in our Notes to Condensed Consolidated Financial Statements in Part I, Item 1 of\nthis Form 10-Q."}